Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 8/12/2019
SIETES contiene 92850 citas

 
 
 1 a 20 de 20 
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Kloprogge F, Workman L, Bormann S, Tékété M, Lefèvre G, Hamed K, Piola P, Ursing J, Kofoed PE, Martensson A, Ngasala B, Björkman A, Ashton M, Hietala SF, Aweeka F, Parikh S, Mwai L, Davis TME, Karunajeewa H, Salman S, Checchi F, Fogg C, Newton PN, Mayxay M, Deloron P, Faucher JF, Nosten F, Ashley EA, McGready R, van Vugt M, Proux S, Price RN, Karbwang J, Ezzet F, Bakshi R, Stepniewska K, White NJ, Guerin PJ, Bames KI, Tarning J. Artemether-lumefantrine dosing for malaria treatment in young children and pregnant women: A pharmacokinetic-pharmacodynamic meta-analysis. PLOS Medicine 2018:12 de junio. [Ref.ID 102769]
2.Tiene citas relacionadas Cita con resumen
Phyo A, Nikhoma S, Stepniewska K, Ashley EA, Nair S, McGready R, Ier Moo C, Al-Saai S, Dondorp AM, Lwin KM, Singhasivanon P, Day NPJ, White NJ, Anderson TJC, Nosten F. Emergence of artemisin-resistant malaria on the western border of Thailand: a longitudinal study. Lancet 2012;379:1960-6. [Ref.ID 93060]
3.
Crawley J, Chu C, Mtove G, Nosten F. Malaria in children. Lancet 2010;375:1468-81. [Ref.ID 88420]
4.
Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, Lwin KM, Ariey F, Hanpithakpong W, Lee SJ, Ringwald P, Silamut K, Imwong M, Chotivanich K, Lim P, Herdman T, An SS, Yeung S, Singhasivanon P, Day NPJ, Lindegardh N, Socheat D, White NJ. Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med 2009;361:455-67. [Ref.ID 86433]
5.
McGready R, Stepniwska K, Lindegardh N, Ashley EA, La Y, Singhasivanon P, White NJ, Nosten F. The pharmacokinetics of artemether and lumefantrine in pregnant women with uncomplicated falciparum malaria. Eur J Clin Pharmacol 2006;62:1021-31. [Ref.ID 78696]
6.Tiene citas relacionadas Cita con resumen
White NJ, Dondorp AM, Nosten F, Day NPJ, on behalf of the SEAQUAMAT study group. Artesunate versus quinine for severe falciparum malaria. Authors' reply. Lancet 2006;367:111-2. [Ref.ID 75930]
7. Cita con resumen
Price R N, Uhlemann AC, Brockman A, McGready R, Ashley E, Phajpun L, Patel R, Laing K, Looaresuwan S, White NJ, Nosten F, Krishna S. Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. Lancet 2004;364:438-47. [Ref.ID 70989]
8.Tiene citas relacionadas Cita con resumen
White N, Nosten F, Björkman A, Marsh K, Snow RW. WHO, the Global Fund, and medical malpractice in malaria treatment. Lancet 2004;363:1160. [Ref.ID 69709]
9.
McGready R, Stepniewska K, Edstein MD, Cho T, Gilveray G, Looaresuwan S, White NJ, Nosten F. The pharmacokinetics of atovaquone and proguanil in pregnant women with acute falciparum malaria. Eur J Clin Pharmacol 2003;59:545-52. [Ref.ID 67630]
10.
Nosten F, Brasseur P. Combination therapy for malaria: the way forward?. Drugs 2002;62:1315-29. [Ref.ID 62158]
11.Tiene citas relacionadas Cita con resumen
Nosten F. Prophylactic effect of Malarone against malaria: all good news?. Lancet 2000;356:1864-5. [Ref.ID 54279]
12. Cita con resumen
Nosten F, van Bugt M, Price R, Luxemburger C, Thway KL, Brockman A, McGready R, Ter Kuile F, Looaresuwan S, White NJ. Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in Western Thailand: a prospective study. Lancet 2000;356:297-302. [Ref.ID 52171]
13. Cita con resumen
Simpson JA, Ter Kuile F, Teja-Isavathram P, Nosten F, Chongsuphajaisiddhi T, Looaresuwan S, Aarons L, White NJ. Population pharmacokinetics of mefloquine in patients with acute falciparum malaria. Clin Pharmacol Ther 1999;66:472-84. [Ref.ID 48380]
14.
Teja-Isavadharm P, Nosten F, Kyle DE, Luxemburger C, Kuile FT, Peggins J O, Brewer TG, White NJ. Comparative bioavailability of oral, rectal, and intramuscular artemether in healthy subjects: use of simultaneous measurement by high performance liquid chromatography and bioassay. Br J Clin Pharmacol 1996;42:599-604. [Ref.ID 30027]
15.
Nosten F, Luxemburger C, Jyle DE, Ballou WR, Wittes J, Wah E, Chongsuphajaisiddhi T, Gordon DM, White NJ, Sadoff J C, Heppner DG, Shoklo SPf66 Malaria Vaccine Trial Group. Randomised double-blind placebo-controlled trial of SPf66 malaria vaccine in children in Northwestern Thailand. Lancet 1996;348:701-7. [Ref.ID 29383]
16. Cita con resumen
Price R N, Nosten F, Luxemburger C, Ter Kuile FO, Paiphun L, Chongsuphajaisiddhi T, White NJ. Effects of artemisinin derivatives on malaria transmissibility. Lancet 1996;347:1654-8. [Ref.ID 28211]
17.
Nosten F, Price R N. New antimalarials. A risk-benefit analysis. Drug Saf 1995;12:264-73. [Ref.ID 23899]
18.
Nosten F, Ter Kuile FO, Luxemburguer C, Woodrow C, Kyle DE, Chongsuphajaisiddhi T, White NJ. Cardiac effects of antimalarial treatment with halofantrine. Lancet 1993;341:1054-6. [Ref.ID 19249]
19.
Ter Kuile FO, Dolan G, Nosten F, Edstein MD, Luxemburguer C, Phaipun L, Chongsuphajaisiddhi T, Webster HK, White NJ. Halofantrine versus mefloquine in treatment of multidrug-resistant falciparum malaria. Lancet 1993;341:1044-9. [Ref.ID 19248]
20. Cita con resumen
White NJ, Waller D, Crawley J, Nosten F, Chapman D, Brewster D, Greenwood BM. Comparison of artemether and chloroquine for severe malaria in Gambian children. Lancet 1992;339:317-21. [Ref.ID 16748]
Seleccionar todas
 
 1 a 20 de 20